BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jain V, Gordon C. Managing pregnancy in inflammatory rheumatological diseases. Arthritis Res Ther. 2011;13:206. [PMID: 21371350 DOI: 10.1186/ar3227] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
Number Citing Articles
1 Levy RA, de Jesús GR, de Jesús NR, Klumb EM. Critical review of the current recommendations for the treatment of systemic inflammatory rheumatic diseases during pregnancy and lactation. Autoimmun Rev 2016;15:955-63. [PMID: 27490204 DOI: 10.1016/j.autrev.2016.07.014] [Cited by in Crossref: 49] [Cited by in F6Publishing: 37] [Article Influence: 9.8] [Reference Citation Analysis]
2 Venturella R, Quaresima P, Micieli M, Rania E, Palumbo A, Visconti F, Zullo F, Di Carlo C. Non-obstetrical indications for cesarean section: a state-of-the-art review. Arch Gynecol Obstet 2018;298:9-16. [DOI: 10.1007/s00404-018-4742-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 3.7] [Reference Citation Analysis]
3 Cavallasca JA. Hot topics in lupus pregnancy. WJR 2013;3:32. [DOI: 10.5499/wjr.v3.i3.32] [Reference Citation Analysis]
4 Hoffmann S, Kohler S, Ziegler A, Meisel A. Glucocorticoids in myasthenia gravis - if, when, how, and how much? Acta Neurol Scand 2014;130:211-21. [DOI: 10.1111/ane.12261] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
5 Kowitz M, Chakradeo K, Hennessey A, Wolski P. Premature live birth in a woman with antisynthetase syndrome following recurrent miscarriages. BMJ Case Rep 2021;14:e240929. [PMID: 33975837 DOI: 10.1136/bcr-2020-240929] [Reference Citation Analysis]
6 Vestergaard C, Wollenberg A, Barbarot S, Christen-Zaech S, Deleuran M, Spuls P, Flohr C, Trzeciak M, von Kobyletzki L, Seneschal J, Paul C, Bieber T, Werfel T, Fölster-Holst R, Darsow U, Gieler U, Svensson Å, Cork M, Stalder JF, De Raeve L, Kunz B, Simon D, Chernyshov P, Hijnen D, Gelmetti C, Ring J, Taieb A, de Bruin-Weller M, Thyssen JP. European task force on atopic dermatitis position paper: treatment of parental atopic dermatitis during preconception, pregnancy and lactation period. J Eur Acad Dermatol Venereol 2019;33:1644-59. [PMID: 31231864 DOI: 10.1111/jdv.15709] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 13.5] [Reference Citation Analysis]
7 Marder W, Ganser MA, Romero V, Hyzy MA, Gordon C, McCune WJ, Somers EC. In utero azathioprine exposure and increased utilization of special educational services in children born to mothers with systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2013;65:759-66. [PMID: 23139238 DOI: 10.1002/acr.21888] [Cited by in Crossref: 35] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
8 Saavedra Salinas MÁ, Barrera Cruz A, Cabral Castañeda AR, Jara Quezada LJ, Arce-salinas CA, Álvarez Nemegyei J, Fraga Mouret A, Orozco Alcalá J, Salazar Páramo M, Cruz Reyes CV, Andrade Ortega L, Vera Lastra OL, Mendoza Pinto C, Sánchez González A, Cruz Cruz PDR, Morales Hernández S, Portela Hernández M, Pérez Cristóbal M, Medina García G, Hernández Romero N, Velarde Ochoa MDC, Navarro Zarza JE, Portillo Díaz V, Vargas Guerrero A, Goycochea Robles MV, García Figueroa JL, Barreira Mercado E, Amigo Castañeda MC. Guías de práctica clínica para la atención del embarazo en mujeres con enfermedades reumáticas autoinmunes del Colegio Mexicano de Reumatología. Parte II. Reumatología Clínica 2015;11:305-15. [DOI: 10.1016/j.reuma.2014.12.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
9 Marder W, Knight JS, Kaplan MJ, Somers EC, Zhang X, O'Dell AA, Padmanabhan V, Lieberman RW. Placental histology and neutrophil extracellular traps in lupus and pre-eclampsia pregnancies. Lupus Sci Med 2016;3:e000134. [PMID: 27158525 DOI: 10.1136/lupus-2015-000134] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 9.6] [Reference Citation Analysis]
10 Briggs AM, Jordan JE, Ackerman IN, Van Doornum S. Establishing cross-discipline consensus on contraception, pregnancy and breast feeding-related educational messages and clinical practices to support women with rheumatoid arthritis: an Australian Delphi study. BMJ Open 2016;6:e012139. [PMID: 27633637 DOI: 10.1136/bmjopen-2016-012139] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
11 Carvalheiras G, Faria R, Braga J, Vasconcelos C. Fetal outcome in autoimmune diseases. Autoimmunity Reviews 2012;11:A520-30. [DOI: 10.1016/j.autrev.2011.12.002] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 4.7] [Reference Citation Analysis]
12 Colla L, Diena D, Rossetti M, Manzione AM, Marozio L, Benedetto C, Biancone L. Immunosuppression in pregnant women with renal disease: review of the latest evidence in the biologics era. J Nephrol 2018;31:361-83. [DOI: 10.1007/s40620-018-0477-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
13 Chighizola CB, Lonati PA, Trespidi L, Meroni PL, Tedesco F. The Complement System in the Pathophysiology of Pregnancy and in Systemic Autoimmune Rheumatic Diseases During Pregnancy. Front Immunol 2020;11:2084. [PMID: 32973817 DOI: 10.3389/fimmu.2020.02084] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
14 Gottlieb AB, Ryan C, Murase JE. Clinical considerations for the management of psoriasis in women. Int J Womens Dermatol 2019;5:141-50. [PMID: 31360745 DOI: 10.1016/j.ijwd.2019.04.021] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
15 Arese V, Murabito P, Ribero S, Panzone M, Tonella L, Fierro MT, Papini M, Quaglino P. Autoimmune connective tissue diseases and pregnancy. G Ital Dermatol Venereol 2019;154:263-76. [PMID: 30650958 DOI: 10.23736/S0392-0488.18.06252-1] [Reference Citation Analysis]
16 de Jesus GR, Mendoza-Pinto C, de Jesus NR, Dos Santos FC, Klumb EM, Carrasco MG, Levy RA. Understanding and Managing Pregnancy in Patients with Lupus. Autoimmune Dis 2015;2015:943490. [PMID: 26246905 DOI: 10.1155/2015/943490] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
17 Heilskov S, Deleuran MS, Vestergaard C. Immunosuppressive and Immunomodulating Therapy for Atopic Dermatitis in Pregnancy: An Appraisal of the Literature. Dermatol Ther (Heidelb) 2020;10:1215-28. [PMID: 33140290 DOI: 10.1007/s13555-020-00457-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Gualtierotti R, Ingegnoli F, Meroni PL. Pre-conceptional exposure to rituximab: comment on the article by Ojeda-Uribe et al. Clin Rheumatol 2013;32:727-8. [PMID: 23636791 DOI: 10.1007/s10067-013-2241-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
19 Ward IM, Knott A. Practical Pearls About Current Rheumatic Medications. Prim Care 2018;45:193-212. [PMID: 29759120 DOI: 10.1016/j.pop.2018.02.003] [Reference Citation Analysis]
20 Al-Emadi S, Abutiban F, El Zorkany B, Ziade N, Al-Herz A, Al-Maini M, Khan B, Ghanem A, Al Rayes H, Al Saleh J, Al-Osaimi H, Østensen M. Enhancing the care of women with rheumatic diseases during pregnancy: challenges and unmet needs in the Middle East. Clin Rheumatol 2016;35:25-31. [PMID: 26304021 DOI: 10.1007/s10067-015-3052-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
21 Ismail F, Abdel-azeem MI, El-haleem HA, Mohammed A, Katta MA, Mahmoud A, Essam S, Osman E. Feto-maternal outcome in patients with systemic sclerosis. The Egyptian Rheumatologist 2013;35:101-6. [DOI: 10.1016/j.ejr.2012.11.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
22 Panchal S, Khare M, Moorthy A, Samanta A. Catch me if you can: a national survey of rheumatologists and obstetricians on the use of DMARDs during pregnancy. Rheumatol Int 2013;33:347-53. [DOI: 10.1007/s00296-012-2418-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
23 Mena-vazquez N. Safety of biologic therapies during pregnancy in women with rheumatic disease. WJR 2015;5:82. [DOI: 10.5499/wjr.v5.i2.82] [Cited by in CrossRef: 1] [Article Influence: 0.2] [Reference Citation Analysis]
24 Hutson JR, Matlow JN, Moretti ME, Koren G. The fetal safety of thiopurines for the treatment of inflammatory bowel disease in pregnancy. J Obstet Gynaecol. 2013;33:1-8. [PMID: 23259868 DOI: 10.3109/01443615.2012.716106] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 5.1] [Reference Citation Analysis]
25 Murray K, Moore L, O’brien C, Clohessy A, Brophy C, Fitzgerald O, Molloy ES, Mongey A, Higgins S, Higgins MF, Minnock P, Lalor J, Mcauliffe FM, Veale DJ. A multidisciplinary approach to reproductive healthcare in women with rheumatic disease. Ir J Med Sci 2020;189:237-43. [DOI: 10.1007/s11845-019-02040-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]